Your browser doesn't support javascript.
loading
SARS-CoV-2 Epidemiology on a Public University Campus in Washington State
Ana A. Weil; Sarah L Sohlberg; Jessica A. O'Hanlon; Amanda M. Casto; Anne W. Emanuels; Natalie K. Lo; Emily P. Greismer; Ariana M. Magedson; Naomi C. Wilcox; Ashley E. Kim; Lewis Back; Christian D. Frazar; Ben Pelle; Thomas R. Sibley; Misja Ilcisin; Jover Lee; Erica L. Ryke; J. Chris Craft; Kristen M. Schwabe-Fry; Kairsten A. Fay; Shari Cho; Peter D. Han; Sarah J. Heidl; Brian A. Pfau; Melissa Truong; Weizhi Zhong; Sanjay R. Srivatsan; Katia F. Harb; Geoffrey S. Gottlieb; James P. Hughes; Deborah A. Nickerson; Christina M. Lockwood; Lea M. Starita; Trevor Bedford; Jay A. Shendure; Helen Y. Chu.
Afiliación
  • Ana A. Weil; University of Washington
  • Sarah L Sohlberg; University of Washington
  • Jessica A. O'Hanlon; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Amanda M. Casto; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Anne W. Emanuels; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Natalie K. Lo; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Emily P. Greismer; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Ariana M. Magedson; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Naomi C. Wilcox; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Ashley E. Kim; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Lewis Back; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
  • Christian D. Frazar; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Ben Pelle; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • Thomas R. Sibley; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • Misja Ilcisin; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • Jover Lee; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • Erica L. Ryke; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • J. Chris Craft; Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Kristen M. Schwabe-Fry; Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Kairsten A. Fay; Fred Hutchinson Cancer Research Center, Seattle, WA USA
  • Shari Cho; Department of Genome Sciences, University of Washington, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Peter D. Han; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Sarah J. Heidl; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Brian A. Pfau; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Melissa Truong; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Weizhi Zhong; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Sanjay R. Srivatsan; Department of Genome Sciences, University of Washington, Seattle, WA USA
  • Katia F. Harb; Department of Environmental Health and Safety, University of Washington, Seattle, WA USA
  • Geoffrey S. Gottlieb; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA, Department of Environmental Health and Safety, U
  • James P. Hughes; Department of Biostatistics, University of Washington, Seattle, WA USA
  • Deborah A. Nickerson; Department of Genome Sciences, University of Washington, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Christina M. Lockwood; Department of Genome Sciences, University of Washington, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Lea M. Starita; Department of Genome Sciences, University of Washington, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Trevor Bedford; Fred Hutchinson Cancer Research Center, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Jay A. Shendure; Department of Genome Sciences, University of Washington, Seattle, WA USA, Brotman Baty Institute for Precision Medicine, Seattle, WA USA
  • Helen Y. Chu; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA USA
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21253227
Artículo de revista
Un artículo publicado en revista científica está disponible y probablemente es basado en este preprint, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver artículo de revista
ABSTRACT
BackgroundTesting programs have been utilized as part of SARS-CoV-2 mitigation strategies on university campuses, and it is not known which strategies successfully identify cases and contain outbreaks. ObjectiveEvaluation of a testing program to control SARS-CoV-2 transmission at a large university. DesignProspective longitudinal study using remote contactless enrollment, daily mobile symptom and exposure tracking, and self-swab sample collection. Individuals were tested if the participant was (1) exposed to a known case, developed new symptoms, or reported high-risk behavior, (2) a member of a group experiencing an outbreak, or (3) at baseline upon enrollment. SettingAn urban, public university during Autumn quarter of 2020 ParticipantsStudents, staff, and faculty. MeasurementsSARS-CoV-2 PCR testing was conducted, and viral genome sequencing was performed. ResultsWe enrolled 16,476 individuals, performed 29,783 SARS-CoV-2 tests, and detected 236 infections. Greek community affiliation was the strongest risk factor for testing positive. 75.0% of positive cases reported at least one of the following symptoms (60.8%), exposure (34.7%), or high-risk behaviors (21.5%). 88.1% of viral genomes (52/59) sequenced from Greek-affiliated students were genetically identical to at least one other genome detected, indicative of rapid SARS-CoV-2 spread within this group, compared to 37.9% (11/29) of genomes from non-Greek students and employees. LimitationsObservational study. ConclusionIn a setting of limited resources during a pandemic, we prioritized testing of individuals with symptoms and high-risk exposure during outbreaks. Rapid spread of SARS- CoV-2 occurred within outbreaks without evidence of further spread to the surrounding community. A testing program focused on high-risk populations may be effective as part of a comprehensive university-wide mitigation strategy to control the SARS-CoV-2 pandemic.
Licencia
cc_by_nc_nd
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Preprint